Sequoia Invests $15M In Chinese Healthcare AI Start-up Deep Intelligent Pharma

Login to View

Beijing-based Deep Intelligent Pharma, a healthcare AI start-up providing new drug research and development services for pharmaceutical companies, announced that it has raised a US$15 million series B round of financing from Sequoia Capital China.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in

China Money Network Subscription

RELATED NEWS